DGX monthly performance report
Explore DGX's monthly returns, drawdown, and seasonality trends — updated every month.
DGX monthly report
—
Key takeaways
- Quest Diagnostics (DGX) closed September 2026 at $246.45, up 2.56% for the month and +34.43% over the trailing 12 months.
- Year-to-date, DGX is +42.02%, outperforming the S&P 500 which has returned +11.70% YTD.
- The stock is trading +21.50% versus its 200-day moving average ($202.83), a bullish technical signal.
- Over the past three years, DGX has outperformed the S&P 500 by +24.23%, with a relative strength index reading of 114.1.
- Win rate over the trailing 39 months stands at 59% — 23 positive months versus 16 negative months.
Quest Diagnostics ended September 2026 at $246.45, posting a monthly return of +2.56%. The S&P 500 returned −0.70% over the same window, leaving relative performance at +3.26%.
The current quarter stands at +16.28% (Q3 2026 (QTD)), while medium-term trend remains constructive: price is +21.50% versus the 200-day moving average ($202.83).
Year-to-date, DGX is +42.02% against SPY +11.70%, a gap of +30.32%. The stock is currently −0.90% below its 52-week high, with maximum 3-year drawdown at −12.90%.
| Period | DGX | S&P 500 (SPY) | Excess return |
|---|---|---|---|
| 1 Day | −0.40% | −0.12% | −0.28% |
| 1 Week | +4.86% | −0.34% | +5.20% |
| 1 Month | +2.56% | −0.70% | +3.26% |
| 3 Months | +22.59% | +2.80% | +19.79% |
| 6 Months | +23.41% | +13.85% | +9.56% |
| YTD | +42.02% | +11.70% | +30.32% |
| 12 Months | +34.43% | +15.01% | +19.42% |
| 3 Years | +95.92% | +71.69% | +24.23% |
| Rank | Month | Return |
|---|---|---|
| #1 | Feb 2026 | +13.30% |
| #2 | Aug 2024 | +10.31% |
| #3 | Jul 2026 | +9.94% |
| #4 | Jun 2026 | +8.75% |
| #5 | Aug 2025 | +8.50% |
| Rank | Month | Return |
|---|---|---|
| #1 | Dec 2025 | −8.27% |
| #2 | Oct 2025 | −7.68% |
| #3 | Mar 2026 | −7.52% |
| #4 | Sep 2023 | −7.33% |
| #5 | Dec 2024 | −7.25% |
| Quarter | Return |
|---|---|
| Q2 2025 | +6.16% |
| Q3 2025 | +6.10% |
| Q4 2025 | −8.95% |
| Q1 2026 | +12.94% |
| Q2 2026 | +8.15% |
| Q3 2026 (QTD) | +16.28% |
| Year | Return |
|---|---|
| 2023 | −11.86% |
| 2024 | +9.41% |
| 2025 | +15.03% |
| 2026 | +42.02% |
| Metric | Value |
|---|---|
| 52-Week High | $248.70 (2026-09-17) |
| 52-Week Low | $171.18 (2026-01-05) |
| Current Price | $246.45 |
| 200-Day Moving Average | $202.83 |
| Price vs 200DMA | +21.50% |
| 3-Year Maximum Drawdown | −12.90% (2024-02-05) |
| Current Drawdown from 52W High | −0.90% |
| RS metric | Value |
|---|---|
| RS Index (3-year, rebased to 100) | 114.1 |
| 3-Year Excess Return vs S&P 500 | +24.23% |
| RS Peak | 115.6 (Apr 2025) |
| RS Trough | 85.7 (Mar 2024) |
| Status | Outperforming Benchmark |
Frequently asked questions
What was DGX's return for this report period?
DGX returned +2.56% in the latest monthly window ending 2026-09-18.
Has DGX outperformed SPY year to date?
YTD DGX: +42.02% vs SPY: +11.70%.
What is DGX's 12-month return?
+34.43% over the trailing 12 months.
Is DGX above or below its 200-day moving average?
Price is +21.50% versus 200DMA ($202.83).
What is the maximum drawdown in the 3-year window?
−12.90% on 2024-02-05.